Wasatch Advisors LP Holds 9.6% Stake in Castle Biosciences
Ticker: CSTL · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Wasatch Advisors LP still owns 9.6% of Castle Biosciences, a strong vote of confidence!**
AI Summary
Wasatch Advisors LP, an investment adviser based in Salt Lake City, Utah, has updated its ownership stake in Castle Biosciences Inc. (CSTL) to 2,590,951 shares of common stock, representing 9.6% of the company's outstanding shares. This filing, an amendment to a previous SC 13G, indicates a significant, but not controlling, passive investment. For investors, this shows a major institutional investor maintains a substantial position in Castle Biosciences, which could be seen as a vote of confidence in the company's long-term prospects.
Why It Matters
This filing confirms a large institutional investor, Wasatch Advisors LP, continues to hold a significant portion of Castle Biosciences, signaling their ongoing belief in the company's value.
Risk Assessment
Risk Level: low — This filing indicates a passive investment by an institutional investor, not a change in control or a major divestment, which generally poses low risk.
Analyst Insight
Investors should note that a prominent institutional investor, Wasatch Advisors LP, maintains a substantial, passive stake in Castle Biosciences. This could be interpreted as a positive signal regarding the company's long-term value, but it doesn't indicate any immediate operational changes or activist intentions.
Key Numbers
- 2,590,951 — Shares Owned (Represents the total number of common stock shares of Castle Biosciences Inc. held by Wasatch Advisors LP.)
- 9.6% — Percent of Class Owned (Indicates the proportion of Castle Biosciences Inc.'s common stock that Wasatch Advisors LP owns, showing a significant stake.)
Key Players & Entities
- Wasatch Advisors LP (company) — the investment adviser filing the SC 13G/A
- Castle Biosciences Inc. (company) — the issuer of the common stock
- 2,590,951 (dollar_amount) — number of shares owned by Wasatch Advisors LP
- 9.6% (dollar_amount) — percentage of class owned by Wasatch Advisors LP
- Salt Lake City, UT (company) — location of Wasatch Advisors LP
- Friendswood, TX (company) — location of Castle Biosciences Inc.
Forward-Looking Statements
- Wasatch Advisors LP will likely maintain its significant stake in Castle Biosciences Inc. for the foreseeable future. (Wasatch Advisors LP) — medium confidence, target: Next 12-24 months
FAQ
What is the primary purpose of this SC 13G/A filing?
The primary purpose of this SC 13G/A filing is for Wasatch Advisors LP to amend its previous Schedule 13G, updating its ownership stake in Castle Biosciences Inc. to 2,590,951 shares, representing 9.6% of the common stock.
Who is the reporting person in this filing and what is their role?
The reporting person is Wasatch Advisors LP, an investment adviser registered under section 203 of the Investment Advisers Act of 1940, as stated in Item 3(e) of the filing.
How many shares of Castle Biosciences Inc. common stock does Wasatch Advisors LP own, and what percentage of the class does this represent?
Wasatch Advisors LP owns 2,590,951 shares of Castle Biosciences Inc. common stock, which represents 9.6% of the class owned, as detailed in Item 9 and Item 11 of the filing.
Does Wasatch Advisors LP have sole or shared voting and dispositive power over these shares?
According to Items 5 and 7, Wasatch Advisors LP has sole voting power over 2,590,951 shares and sole dispositive power over 2,590,951 shares, with zero shared voting or dispositive power.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the common stock of Castle Biosciences Inc. is 14843C105, as stated in the filing under 'Title of Class of Securities' and Item 2(e).
From the Filing
EDGAR Filing Documents for 0000814133-24-000022 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000814133-24-000022 Filing Date 2024-02-09 Accepted 2024-02-09 12:43:41 Documents 1 Document Format Files Seq Description Document Type Size 1 cstl224.txt SC 13G/A 2471 Complete submission text file 0000814133-24-000022.txt 4202 Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777 WASATCH ADVISORS LP (Filed by) CIK : 0000814133 (see all company filings) EIN. : 870319391 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A Mailing Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 Business Address 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD TX 77546 866-788-9007 CASTLE BIOSCIENCES INC (Subject) CIK : 0001447362 (see all company filings) EIN. : 770701774 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-91094 | Film No.: 24613571 SIC : 8071 Services-Medical Laboratories (CF Office: 08 Industrial Applications and Services)